Compare TSE & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSE | HBIO |
|---|---|---|
| Founded | 2010 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 22.1M |
| IPO Year | 2014 | 2000 |
| Metric | TSE | HBIO |
|---|---|---|
| Price | $0.38 | $0.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $2.50 |
| AVG Volume (30 Days) | ★ 637.6K | 537.0K |
| Earning Date | 02-13-2026 | 03-12-2026 |
| Dividend Yield | ★ 5.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,133,800,000.00 | $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.53 | $7.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.37 | $0.28 |
| 52 Week High | $5.99 | $1.43 |
| Indicator | TSE | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 32.99 | 47.70 |
| Support Level | $0.42 | $0.53 |
| Resistance Level | $0.51 | $0.65 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 45.93 |
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.